These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20398593)

  • 1. Transforming the current infrastructure for combating HBV and HCV infections.
    Kim WR; Ward JW; Cheever LW; Dan C; Dee L; Zola J
    J Fam Pract; 2010 Apr; 59(4 Suppl):S65-70. PubMed ID: 20398593
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for prevention, screening, and diagnosis of HBV and HCV infections.
    Peters MG; Weinbaum C; Tan L; Baine WB; Dienstag JL; Liang TJ; So S
    J Fam Pract; 2010 Apr; 59(4 Suppl):S29-35. PubMed ID: 20398588
    [No Abstract]   [Full Text] [Related]  

  • 3. Transforming strategies for the prevention of chronic HBV and HCV infections.
    Ward JW; Hu DJ; Alter MJ; Kanwal F; Taylor C; Block JM; Caballero JB; Chase D; Saly M; Sandt L; Swan T
    J Fam Pract; 2010 Apr; 59(4 Suppl):S23-8. PubMed ID: 20398587
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic viral hepatitis as a public health issue in the world.
    Lavanchy D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):991-1008. PubMed ID: 19187863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming strategies to provide access to care.
    Jacobson IM; Wang S; Edlin BR; Smith VK; Chow EA
    J Fam Pract; 2010 Apr; 59(4 Suppl):S59-64. PubMed ID: 20398592
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fighting against viral hepatitis B and C: which policy for prevention?].
    Jullien-Depradeux AM; Le Quellec-Nathan M; Postel-Vinay N; Coquin Y; Dab W
    Rev Prat; 2005 Mar; 55(6):585-6. PubMed ID: 15913108
    [No Abstract]   [Full Text] [Related]  

  • 7. Institute of Medicine recommendations for the prevention and control of hepatitis B and C.
    Mitchell AE; Colvin HM; Palmer Beasley R
    Hepatology; 2010 Mar; 51(3):729-33. PubMed ID: 20186842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dawn of a new era: transforming our domestic response to hepatitis B & C.
    El-Serag H; Lok AS; Thomas DL
    Gastroenterology; 2010 Apr; 138(4):1225-30, 1230.e1-3. PubMed ID: 20176024
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of factors affecting HBV and HCV infections in premature children].
    Chlebna-Sokół D; Ligenza I; Krajewski P
    Przegl Epidemiol; 1997; 51(3):239-46. PubMed ID: 9411494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B and C in children.
    Hsu EK; Murray KF
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jun; 5(6):311-20. PubMed ID: 18414457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public health management of perinatal hepatitis B virus.
    Libbus MK; Phillips LM
    Public Health Nurs; 2009; 26(4):353-61. PubMed ID: 19573214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic viral hepatitis B and C. Epidemiology, diagnosis, etiology, prevention].
    Castera L; Dhumeaux D; Pawlotsky JM
    Rev Prat; 2001 Jun; 51(11):1247-57. PubMed ID: 11503496
    [No Abstract]   [Full Text] [Related]  

  • 13. Overview of the viral hepatitis problem.
    Lok AS; Kim WR; El-Serag HB; Maddrey WC
    J Fam Pract; 2010 Apr; 59(4 Suppl):S11-6. PubMed ID: 20398585
    [No Abstract]   [Full Text] [Related]  

  • 14. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
    Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
    Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Funding the elimination of viral hepatitis: donors needed.
    Gore C; Hicks J; Deelder W
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):843-845. PubMed ID: 29100843
    [No Abstract]   [Full Text] [Related]  

  • 16. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R; Miller J; Lungley S; Baker M
    N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update.
    Smith BD; Jorgensen C; Zibbell JE; Beckett GA
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S49-53. PubMed ID: 22715214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral hepatitis and HIV in Africa.
    Modi AA; Feld JJ
    AIDS Rev; 2007; 9(1):25-39. PubMed ID: 17474311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
    Chakravarti A; Verma V; Jain M; Kar P
    Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.